Buy Addyi
Addyi

$6.51
Active Ingredient
Delivery
Airmail (14-21 days) | EMS trackable (5-9 days)
Prescription
Issued on site / Included
Availability
In Stock
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Addyi Properties

Active Ingredients
Primary Category
Pharmacological Class
Serotonin receptor agonist/antagonist
Minor Side Effects
Moderate Side Effects
Dosage Forms
Tablet
Administration Route
Oral
Mechanism of Action
Acts on brain chemicals to increase sexual desire in women.
Prescription Status
Rx
Patient Summary
Used to treat low sexual desire in premenopausal women.
Onset Time
May take several weeks before improvement is noticed.
Duration
Effect continues with regular daily use; stop if side effects persist.
Storage Instructions
Store at room temperature, away from moisture.
Age Restrictions
Not for use in children or men
Pregnancy Use
Do not use during pregnancy; consult doctor.

About Addyi

Addyi (flibanserin) is a prescription-only oral medication indicated for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in pre-menopausal women. Belonging to the class of serotonin-modulating agents, each 100 mg pill is taken once daily at bedtime. While the drug received FDA approval in the United States in 2015, it has not been listed on the Australian Therapeutic Goods Administration (TGA) register, meaning it is not formally approved for use in Australia. Clinical studies have shown that Addyi can modestly increase the frequency of satisfying sexual events and improve desire scores when taken as directed. Some clinicians consider it for off-label use only under specialist supervision because of its interaction profile and the need for careful patient selection.

What is Addyi?

Addyi is the brand name for flibanserin, a serotonin-receptor agonist/antagonist developed by Sprout Pharmaceuticals. It is classified as a central nervous system-acting agent specifically designed to address low sexual desire in pre-menopausal women. The medication received its first regulatory approval in the United States in 2015 after extensive phase III trials demonstrated modest efficacy. In Australia, Addyi remains unregistered, so it can only be obtained through special importation channels or via licensed online pharmacies that operate under international regulations.

How Addyi Works

Flibanserin exerts its effect by binding to serotonin receptors in the brain. It acts as an agonist at 5-HT₁A receptors while antagonising 5-HT₂A receptors, resulting in a net increase in dopaminergic and noradrenergic activity in areas that regulate sexual desire. This shift in neurotransmitter balance is thought to enhance arousal pathways and reduce inhibitory signaling that contributes to low libido. After oral administration, the drug reaches peak plasma concentrations within about one hour; its half-life is roughly 11 hours, allowing once-daily dosing. Metabolism occurs primarily via the CYP3A4 enzyme, and the medication is excreted in both urine and feces. Because its action is central rather than peripheral, the therapeutic effect emerges after several weeks of consistent use, with many patients reporting noticeable changes after four to eight weeks.

Why Addyi is Used for Sexual Health Conditions

  • Targeting Neurochemical Imbalance - HSDD is associated with altered serotonergic signaling; flibanserin directly corrects this by modulating 5-HT₁A and 5-HT₂A receptors, which restores a more favourable dopaminergic tone for desire.
  • Evidence-Based Efficacy - Phase III trials (e.g., the DAISY and VIOLET studies) demonstrated a statistically significant increase in weekly satisfying sexual events compared with placebo (approximately .5-1. additional events per week).
  • Guideline Placement - In the United States, professional societies such as the American College of Obstetricians and Gynecologists list flibanserin as a second-line pharmacologic option after lifestyle optimisation and counseling.
  • Convenient Oral Administration - The once-daily pill fits easily into routine medication schedules, unlike some injectable or hormonal therapies that require more frequent visits.
  • Non-Hormonal Approach - For women who cannot or prefer not to use estrogen-based treatments, Addyi provides a mechanism that does not rely on systemic hormone modulation, reducing certain endocrine-related risks.
  • Limited Alternatives - Few approved agents specifically address low sexual desire; most clinicians rely on off-label use of testosterone or psychotherapy, making Addyi a distinct pharmacologic choice when appropriate.

Off-Label and Investigational Uses of Addyi

Current peer-reviewed literature does not support robust off-label applications of flibanserin beyond its approved indication in pre-menopausal women with HSDD. Small exploratory studies have examined its effect on male sexual desire, but results were inconclusive and regulatory bodies have not endorsed such use. Consequently, any off-label prescribing should occur only under the direct supervision of a qualified specialist who can weigh potential benefits against the well-documented interaction risks.

Off-label use should only be considered under the supervision of a qualified healthcare provider.

Is Addyi Right for You?

Addyi is best suited for pre-menopausal women who have experienced a persistent lack of sexual desire for at least six months and for whom non-pharmacologic strategies have not yielded improvement. Ideal candidates are generally healthy, have normal liver function, and do not consume alcohol while taking the medication. Women with severe hepatic impairment, uncontrolled hypertension, or a history of syncope should avoid flibanserin. Although the drug has not been formally evaluated in pregnancy, it is contraindicated during gestation and lactation because safety data are lacking. Elderly patients may require dose adjustments if renal or hepatic clearance is reduced. Ultimately, the decision rests on a thorough clinical assessment that balances expected benefit with the need for strict alcohol avoidance.

Taking Addyi Effectively

  • Timing: Take the 100 mg tablet at bedtime, ideally after a light snack, to minimise daytime drowsiness.
  • Alcohol Avoidance: Do not consume any alcohol within three hours before or after the dose; even modest intake can precipitate severe hypotension and syncope.
  • Missed Dose: If a dose is forgotten, take it as soon as you remember unless it is close to the next scheduled dose-then skip the missed tablet and continue with the regular bedtime regimen.
  • Drug Interactions: Avoid concurrent use of strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) as they increase flibanserin plasma levels and heighten adverse-event risk.
  • Travel Considerations: When crossing international borders, keep the medication in its original packaging with a copy of the prescription and a letter from your prescriber to satisfy customs requirements.

Consistent daily use for at least four weeks is necessary before evaluating therapeutic response.

Understanding Side Effects and How to Manage Them

The most common adverse events-dizziness, somnolence, nausea, and fatigue-arise from flibanserin’s central nervous system activity. Drinking water and rising slowly from a seated position can lessen dizziness, while taking the pill with a small snack may reduce nausea. If excessive sleepiness interferes with daily tasks, discuss timing adjustments or a trial of a lower initial dose with your clinician.

Rare but serious effects include profound hypotension, syncope, and severe hepatic injury. These are often linked to alcohol consumption or concomitant CYP3A4 inhibition. Immediate medical attention is warranted if you experience sudden fainting, chest pain, or jaundice.

Patient education on the importance of alcohol abstinence and awareness of drug-interaction warnings dramatically reduces the likelihood of severe events.

Buying Addyi from Our Online Pharmacy

Why Choose Our Service?

Acquiring Addyi can be challenging in Australia because the medication is not TGA-registered. Our online pharmacy streamlines the importation process, ensuring you receive a legitimate product that meets international quality standards while maintaining privacy and convenience.

Quality & Safety

We partner with licensed international pharmacies that source Addyi directly from the manufacturer or certified distributors. Each shipment is verified for authenticity, stored under controlled conditions, and accompanied by a full list of batch-specific documentation.

Pricing & Access

Because Addyi is a brand-only product, the cost can be high. Our platform negotiates bulk pricing with partner pharmacies, passing savings on to you. In many cases, the price of a 30-day supply is comparable to generic alternatives for other sexual-health agents, and we offer a 10 % discount on all repeat orders.

Discreet Delivery

Orders are packaged in unmarked, tamper-evident boxes. Standard shipping arrives within 3 weeks, while express service-available for an additional fee-delivers in about 7 days. All deliveries comply with Australian customs regulations to minimise delays.

Frequently Asked Questions

  • How long will it take before I notice an improvement in desire? Most clinical trials observed a measurable increase in satisfying sexual events after four weeks, with continued gains up to eight weeks of daily dosing.

  • Can I take Addyi with other hormonal contraceptives? Yes, Addyi does not interfere with the efficacy of combined oral contraceptives or intrauterine devices, but you should still discuss all medications with your prescriber.

  • What should I do if I accidentally consume alcohol after taking Addyi? If you experience dizziness, light-headedness, or fainting, lie down with your legs elevated and seek medical attention promptly. Preventative avoidance is the safest strategy.

  • Is there any monitoring required while I’m on Addyi? Baseline liver function tests are recommended, especially if you have a history of hepatic disease. Periodic blood pressure checks are also prudent given the risk of hypotension.

  • How does Addyi compare to testosterone therapy for low desire? Testosterone primarily raises peripheral androgen levels, whereas Addyi works centrally on serotonin pathways. For women without androgen deficiency, Addyi may be preferred; however, direct comparative studies are limited.

  • Can men use Addyi to treat low libido? Current evidence does not support its efficacy in males, and it is not approved for that purpose. Off-label use in men remains experimental and should only be considered within a research setting.

  • Will taking Addyi affect my ability to drive or operate machinery? Because somnolence is a common side effect, you should assess your alertness before engaging in activities that require sustained attention, especially during the first few weeks of therapy.

  • Is Addyi covered by Australian Medicare or private health insurance? As an unregistered product, it is not listed on the Pharmaceutical Benefits Scheme (PBS) and is generally excluded from standard private insurance coverage. Costs are therefore out-of-pocket unless a special rebate applies.

  • What should I do if I miss a dose for more than 24 hours? Restart the regimen at the regular bedtime dose; there is no need for a loading dose. Consistency is key to achieving therapeutic effect.

  • Are there any dietary restrictions besides alcohol? No specific food interactions have been identified, but taking the tablet with a light snack can help minimise nausea.

  • Can I become pregnant while taking Addyi? Flibanserin is not recommended during pregnancy due to insufficient safety data. If you become pregnant, discontinue the medication and inform your obstetrician promptly.

Glossary

5-HT₁A Receptor
A subtype of serotonin receptor that, when activated, tends to increase dopamine and norepinephrine release, contributing to mood and sexual desire regulation.
CYP3A4
A liver enzyme responsible for metabolising many drugs; inhibitors of CYP3A4 can raise flibanserin levels and heighten side-effect risk.
Hypoactive Sexual Desire Disorder (HSDD)
A persistent lack of sexual desire causing personal distress, not attributable to other medical, psychiatric, or relationship factors.

Disclaimer

The information presented about Addyi is intended for general educational purposes and does not substitute professional medical consultation. All decisions regarding its use-including any off-label applications-should be made under the supervision of a qualified healthcare provider. Readers are presumed to be adult individuals capable of making informed health choices. Our online pharmacy provides a pathway to obtain Addyi for those who encounter limited availability through conventional pharmacies or who seek more affordable options. Always discuss any medication changes with your doctor before initiating, adjusting, or stopping therapy.

External Resources about Addyi


Information Prepared By

Sarah Jones
Tosin (Olalekan) Olaluwoye, MD, PhD